Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'nonsmall cell lung carcinoma' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 124 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hainsworth, JD; Burris, HA; Billings, FT; Bradof, JE; Baker, M; Greco, FA
      Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network

      CANCER
    2. Kasuga, I; Makino, S; Kiyokawa, H; Katoh, H; Ebihara, Y; Ohyashiki, K
      Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma

      CANCER
    3. Greco, FA; Burris, HA; Gray, JR; Raefsky, EL; Dobbs, C; Smith, S; Rinaldi, D; Morrissey, LH; Erland, JB; Litchy, S; Hainsworth, JD
      Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy forresected nonsmall cell lung carcinoma - A feasibility study of the Minnie Pearl Cancer Research Network

      CANCER
    4. Lilenbaum, RC; Schwartz, MA; Seigel, L; Belette, F; Blaustein, A; Wittlin, FN; Davila, E
      Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma

      CANCER
    5. Ardizzoni, A; Cafferata, MA; Paganuzzi, M; Filiberti, R; Marroni, P; Neri, M; Fontana, V; Nicolo, G; Perdelli, L; Stampino, CG; Rosso, R; Puntoni, R
      Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

      CANCER
    6. Uchitomi, Y; Mikami, I; Kugaya, A; Nakano, T; Okuyama, T; Akechi, T; Okamura, H
      Physician support and patient psychologic responses after surgery for nonsmall cell lung carcinoma - A prospective observational study

      CANCER
    7. Ahrendt, SA; Decker, PA; Alawi, EA; Zhu, YR; Sanchez-Cespedes, M; Yang, SC; Haasler, GB; Kajdacsy-Balla, A; Demeure, MJ; Sidransky, D
      Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung

      CANCER
    8. Socinski, MA; Rosenman, JG; Halle, J; Schell, MJ; Lin, YH; Russo, S; Rivera, MP; Clark, J; Limentani, S; Fraser, R; Mitchell, W; Detterbeck, FC
      Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable Stage IIIA/B nonsmall cell lung carcinoma - A modified Phase I/II trial

      CANCER
    9. Hirsh, V; Langleben, A; Ayoub, J; Cormier, Y; Pintos, J; Iglesias, JL
      Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma - A phase II multicenter trial

      CANCER
    10. Mac Manus, MP; Hicks, RJ; Ball, DL; Kalff, V; Matthews, JP; Salminen, E; Khaw, P; Wirth, A; Rischin, D; McKenzie, A
      F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma - Powerful correlation with survival and high impact on treatment

      CANCER
    11. Shepherd, FA; Dancey, J; Arnold, A; Neville, A; Rusthoven, J; Johnson, RD; Fisher, B; Eisenhauer, E
      Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma - A study of the National Cancer Institute of Canada Clinical Trials Group

      CANCER
    12. Natsume, T; Kobayashi, M; Fujimoto, S
      Association of p53 gene mutations with sensitivity to TZT-1027 in patientswith clinical lung and renal carcinoma

      CANCER
    13. Izumi, M; Nakanishi, Y; Yoshino, I; Nakashima, M; Watanabe, T; Hara, N
      Expression of tumor-associated antigen RCAS1 correlates significantly withpoor prognosis in nonsmall cell lung carcinoma

      CANCER
    14. Kosmas, C; Tsavaris, N; Vadiaka, M; Stavroyianni, N; Koutras, A; Malamos, N; Onyenadum, A; Rokana, S; Polyzos, A; Kalofonos, HP
      Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

      CANCER
    15. Sweeney, CJ; Zhu, JM; Sandler, AB; Schiller, J; Belani, CP; Langer, C; Krook, J; Harrington, D; Johnson, DH
      Outcome of patients with a performance status of 2 in Eastern cooperative oncology group study E1594 - A phase III trial in patients with metastatic nonsmall cell lung carcinoma

      CANCER
    16. Toomey, D; Smyth, G; Condron, C; Kay, E; Conroy, R; Foley, D; Hong, C; Hogan, B; Toner, S; McCormick, P; Broe, P; Kelly, C; Bouchier-Hayes, D
      Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma - Tumor size and lymph node status remain the most important prognostic features

      CANCER
    17. Yano, T; Takeo, S
      Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues

      CANCER
    18. Edelman, MJ; Gandara, DR; Lau, DHM; Lara, P; Lauder, IJ; Tracy, D
      Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel

      CANCER
    19. Law, A; Karp, DD; Dipetrillo, T; Daly, BT
      Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma

      CANCER
    20. Offersen, BV; Pfeiffer, P; Hamilton-Dutoit, S; Overgaard, J
      Patterns of angiogenesis in nonsmall-cell hung carcinoma

      CANCER
    21. Andre, F; Grunenwald, D; Pujol, JL; Girard, P; Dujon, A; Brouchet, L; Brichon, PY; Westeel, V; Le Chevalier, T
      Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy Should prophylactic cranial irradiation be reconsidered?

      CANCER
    22. Vora, SA; Daly, BDT; Blaszkowsky, L; McGrath, JJ; Bankoff, M; Supran, S; Dipetrillo, TA
      High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell long carcinoma

      CANCER
    23. Ricci, S; Antonuzzo, A; Galli, L; Tibaldi, C; Bertuccelli, M; Pegna, AL; Petruzzelli, S; Bonifazi, V; Orlandini, C; Conte, PF
      A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma

      CANCER
    24. Ameshima, S; Ishizaki, T; Demura, Y; Imamura, Y; Miyamori, I; Mitsuhashi, H
      Increased secretory leukoprotease inhibitor in patients with nonsmall celllung carcinoma

      CANCER
    25. Shiba, M; Kohno, H; Kakizawa, K; Iizasa, T; Otsuji, M; Saitoh, Y; Hiroshima, K; Ohwada, H; Fujisawa, T
      Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma

      CANCER
    26. Uchitomi, Y; Mikami, I; Kugaya, A; Akizuki, N; Nagai, K; Nishiwaki, Y; Akechi, T; Okamura, H
      Depression after successful treatment for nonsmall cell lung carcinoma - A3-month follow-up study

      CANCER
    27. Bajetta, E; Stani, SC; De Candis, D; Bidoli, P; Mariani, L; Zilembo, N; Pozzi, P; Procopio, G
      Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial

      CANCER
    28. King, TC; Akerley, W; Fan, AC; Moore, T; Mangray, S; Chen, MH; Safran, H
      p53 mutations do not predict response to paclitaxel in metastatic nonsmallcell lung carcinoma

      CANCER
    29. Kosmas, C; Tsavaris, NB; Polyzos, A; Kalofonos, HP; Sepsas, E; Malamos, NA; Vadiaka, M; Dosios, T; Antonopoulos, MJ
      A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

      CANCER
    30. Hejna, M; Kornek, GV; Raderer, M; Ulrich-Pur, H; Fiebiger, WCC; Marosi, L; Schneeweiss, B; Greul, R; Scheithauer, W
      Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor

      CANCER
    31. Socinski, MA; Rosenman, JG; Schell, MJ; Halle, J; Russo, S; Rivera, MP; Clark, J; Limentani, S; Fraser, R; Mitchell, W; Detterbeck, FC
      Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma - A modified phase I trial

      CANCER
    32. Mok, TSK; Zee, B; Chan, ATC; Yeo, W; Yang, WT; Yim, A; Leung, SF; Nguyen, B; Leung, TWT; Johnson, P
      A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

      CANCER
    33. Hainsworth, JD; Burris, HA; Litchy, S; Morrissey, LH; Barton, JH; Bradof, JE; Greco, FA
      Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma - A Minnie Pearl Cancer Research Network Phase II trial

      CANCER
    34. Rodriguez, J; Cortes, J; Calvo, E; Azinovic, I; Fernandez-Hildago, O; Martinez-Monge, R; Garzon, C; de Irala, J; Martinez-Aguillo, M; Cajal, TRY; Brugarolas, A
      Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma - A Phase II study

      CANCER
    35. Sugarbaker, DJ; Strauss, GM
      Extent of surgery and survival in early lung carcinoma - Implications for overdiagnosis in stage IA nonsmall cell lung carcinoma

      CANCER
    36. Werle, B; Kraft, C; Lah, TT; Kos, J; Schanzenbacher, U; Kayser, K; Ebert, W; Spiess, E
      Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma

      CANCER
    37. Ceresoli, GL; Dell'Oro, S; Passoni, P; Villa, E
      Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma

      CANCER
    38. Choy, H; Shyr, Y; Cmelak, AJ; Mohr, PJ; Johnson, DH
      Patterns of practice survey for nonsmall cell lung carcinoma in the US

      CANCER
    39. Hainsworth, JD; Burris, HA; Litchy, S; Erland, JB; Hon, JK; Brierre, JE; Greco, FA
      Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients - A minnie pearl cancer research network Phase II trial

      CANCER
    40. Miller, VA; Ng, KK; Krug, LM; Perez, W; Pizzo, B; Heelen, RT; Kris, MG
      Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

      CANCER
    41. Ichinose, Y; Yosimori, K; Yoneda, S; Kuba, M; Kudoh, S; Niitani, H
      UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma - A multiinstitutional Phase II trial

      CANCER
    42. Hunt, JD; Robert, EG; Zieske, AW; Bautista, AP; Bukara, M; Lei, DH; Shellito, JE; Nelson, S; Kolls, JK; Skrepnik, N
      Orthotopic human lung carcinoma xenografts in BALB/c mice immunosuppressedwith anti-CD4 monoclonal antibodies and chronic alcohol consumption

      CANCER
    43. Buccheri, G; Ferrigno, D
      Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma - A Phase II study

      CANCER
    44. Feliu, J; Gomez, LL; Madronal, C; Espinosa, E; Espinosa, J; Giron, CG; Martinez, B; Castro, J; De la Gandara, I; Baron, MG
      Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

      CANCER
    45. Bonner, JA; Garces, YI; Sawyer, TE; Gould, PM; Foote, RL; Deschamps, C; Lange, CM; Li, HZ
      Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma

      CANCER
    46. Fukuse, T; Hirata, T; Naiki, H; Hitomi, S; Wada, H
      Expression of proliferating cell nuclear antigen and CD44 variant isoformsin the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases

      CANCER
    47. Ng, KK; Kris, MG; Ginsberg, RJ; Heelan, RT; Pisters, KMW; Miller, VA; Grant, SG; Bains, M; Rusch, V; Rosenzweig, KE; Martini, N
      Induction chemotherapy employing dose-intense cisplatin with mitomycin andvinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma

      CANCER
    48. Yang, CH; Cheng, AL; Yeh, KH; Yu, CJ; Lin, JF; Yang, PC
      High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma

      CANCER
    49. Dautzenberg, B; Arriagada, R; Chammard, AB; Jarema, A; Mezzetti, M; Mattson, K; Lagrange, JL; Le Pechoux, C; Lebeau, B; Chastang, C
      A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma

      CANCER
    50. Franciosi, V; Cocconi, G; Michiara, M; Di Costanzo, F; Fosser, V; Tonato, M; Carlini, P; Boni, C; Di Sarra, S
      Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma A prospective study

      CANCER
    51. Hainsworth, JD; Burris, HA; Erland, JB; Morrissey, LH; Meluch, AA; Kalman, LA; Hon, JK; Scullin, DC; Smith, SW; Greco, FA
      Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

      CANCER
    52. Font, A; Moyano, AJ; Puerto, JM; Tres, A; Garcia-Giron, C; Barneto, I; Anton, A; Sanchez, JJ; Salvador, A; Rosell, R
      Increasing dose intensity of cisplatin-etoposide in advanced nonsmall celllung carcinoma - A phase III randomized trial of the Spanish Lung Cancer Group

      CANCER
    53. Viallet, J; Brassard, MA; Souhami, L; Ayoub, J; Del Vecchio, P; Kreisman, H; Guerra, J; Gruber, J; Langleben, A; Hohneker, J; Rousseau, P
      A phase I II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma

      CANCER
    54. Pignon, T; Ruggieri, S; Boutin, C; Gouvernet, J; Irisson, M; Juin, P; Astoul, P
      Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma

      CANCER
    55. Shieh, DB; Godleski, J; Herndon, JE; Azuma, T; Mercer, H; Sugarbaker, DJ; Kwiatkowski, DJ
      Cell motility as a prognostic factor in stage I nonsmall cell lung carcinoma - The role of gelsolin expression

      CANCER
    56. SANCHEZPERNAUTE A; TORRES A; INIESTA P; HERNANDO F; GOMEZ A; GONZALEZ O; DEJUAN C; PEREZAGUIRRE E; MAESTRO ML; LOPEZASENJO JA; BENITO M; BALIBREA JL
      PROGNOSTIC-SIGNIFICANCE OF P53 GENE-MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE LUNG

      Oncology Reports
    57. VANSTEENKISTE J; DELEYN P; DENEFFE G; MENTEN J; LERUT T; DEMEDTS M
      PRESENT STATUS OF INDUCTION TREATMENT IN STAGE IIIA-N2 NONSMALL CELL LUNG-CANCER - A REVIEW

      European journal of cardio-thoracic surgery
    58. VONLANTHEN S; HEIGHWAY J; TSCHAN MP; BORNER MM; ALTERMATT HJ; KAPPELER A; TOBLER A; FEY MF; THATCHER N; YARBROUGH WG; BETTICHER D
      EXPRESSION OF P16INK4A P16-ALPHA AND P19ARF/P16-BETA IS FREQUENTLY ALTERED IN NONSMALL CELL LUNG-CANCER AND CORRELATES WITH P53 OVEREXPRESSION/

      Oncogene
    59. LANGENDIJK HA; LAMERS RJS; TENVELDE GPM; SANDERS DGM; DEJONG JMA; KESSELS F; WOUTERS EFM
      IS THE CHEST RADIOGRAPH A RELIABLE TOOL IN THE ASSESSMENT OF TUMOR RESPONSE AFTER RADIOTHERAPY IN NONSMALL CELL LUNG-CARCINOMA

      International journal of radiation oncology, biology, physics
    60. TAGAWA M; MURATA M; KIMURA H
      PROGNOSTIC VALUE OF MUTATIONS AND A GERM-LINE POLYMORPHISM OF THE P53GENE IN NONSMALL CELL LUNG-CARCINOMA - ASSOCIATION WITH CLINICOPATHOLOGICAL FEATURES

      Cancer letters
    61. NAGAMACHI Y; TANI M; SHIMIZU K; TSUDA H; NIITSU Y; YOKOTA J
      ORTHOTOPIC GROWTH AND METASTASIS OF HUMAN NONSMALL CELL LUNG-CARCINOMA CELLS INJECTED INTO THE PLEURAL CAVITY OF NUDE-MICE

      Cancer letters
    62. VANSTEENKISTE JF; DELEYN PR; DENEFFE GJ; LERUT TE; DEMEDTS MG
      CLINICAL PROGNOSTIC FACTORS IN SURGICALLY TREATED STAGE IIIA-N2 NONSMALL CELL LUNG-CANCER - ANALYSIS OF THE LITERATURE

      Lung cancer
    63. WILLIAMS J; ENGER C; WHARAM M; TSAI D; BREM H
      STEREOTAXIC RADIOSURGERY FOR BRAIN METASTASES - COMPARISON OF LUNG-CARCINOMA VS. NON-LUNG TUMORS

      Journal of neuro-oncology
    64. HEJNA M; KORNEK GV; RADERER M; SCHNEEWEISS B; GREUL R; WEINLANDER G; VALENCAK J; HUBER H; SCHEITHAUER W
      MITOMYCIN-C, VINORELBINE, CARBOPLATIN PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR TREATMENT OF ADVANCED NONSMALL CELL LUNG-CARCINOMA

      Oncology
    65. ABBONA G; PAPOTTI M; VIBERTI L; MACRI L; STELLA A; BUSSOLATI G
      CHROMOGRANIN-A GENE-EXPRESSION IN NONSMALL CELL LUNG CARCINOMAS

      Journal of pathology
    66. HIGASHIYAMA M; KODAMA K; YOKOUCHI H; TAKAMI K; ADACHI M; TAKI T; ISHIGURO S; NAKAMORI S; YOSHIE O; MIYAKE M
      KAI1 CD82 EXPRESSION IN NONSMALL CELL LUNG-CARCINOMA IS A NOVEL, FAVORABLE PROGNOSTIC FACTOR - AN IMMUNOHISTOCHEMICAL ANALYSIS/

      Cancer
    67. TRAN TA; KALLAKURY BVS; AMBROS RA; ROSS JS
      PROGNOSTIC-SIGNIFICANCE OF TUMOR NECROSIS FACTORS AND THEIR RECEPTORSIN NONSMALL CELL LUNG-CARCINOMA

      Cancer
    68. KOUROUSIS C; ANDROULAKIS N; KAKOLYRIS S; SOUGLAKOS J; MALTEZAKIS G; METAXARIS G; CHALKIADAKIS G; SAMONIS G; VLACHONIKOLIS J; GEORGOULIAS V
      FIRST-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CARCINOMA WITH DOCETAXEL AND VINORELBINE

      Cancer
    69. BONNER JA; MCGINNIS WL; STELLA PJ; MARSCHKE RF; SLOAN JA; SHAW EG; MAILLIARD JA; CREAGAN ET; AHUJA RK; JOHNSON PA
      THE POSSIBLE ADVANTAGE OF HYPERFRACTIONATED THORACIC RADIOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG-CARCINOMA - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP PHASE-III STUDY

      Cancer
    70. GOTO K; KODAMA T; HOJO F; KUBOTA K; KAKINUMA R; MATSUMOTO T; OHMATSU H; SEKINE I; NAGAI K; NISHIWAKI Y
      CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH NONSMALL CELL LUNG-CARCINOMA WITH ELEVATED SERUM PROGASTRIN-RELEASING PEPTIDE LEVELS

      Cancer
    71. CHANG AY; KIM K; BOUCHER H; BONOMI P; STEWART JA; KARP DD; BLUM RH
      A RANDOMIZED PHASE-II TRIAL OF ECHINOMYCIN, TRIMETREXATE, AND CISPLATIN PLUS ETOPOSIDE IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1587)

      Cancer
    72. CHEN FF; YAN JJ; LAI WW; JIN YT; SU IJ
      EPSTEIN-BARR-VIRUS-ASSOCIATED NONSMALL CELL LUNG-CARCINOMA - UNDIFFERENTIATED LYMPHOEPITHELIOMA-LIKE-CARCINOMA AS A DISTINCT ENTITY WITH BETTER PROGNOSIS

      Cancer
    73. NISMAN B; LAFAIR J; HECHING N; LYASS O; BARAS M; PERETZ T; BARAK V
      EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN, CYFRA-21-1, AND CARCINOEMBRYONIC ANTIGEN IN NONSMALL CELL LUNG-CARCINOMA - DOES THE COMBINED USE OF CYTOKERATIN MARKERS GIVE ANY ADDITIONAL INFORMATION

      Cancer
    74. LILENBAUM RC; LANGENBERG P; DICKERSIN K
      SINGLE-AGENT VERSUS COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA - A METAANALYSIS OF RESPONSE, TOXICITY,AND SURVIVAL

      Cancer
    75. COLONOTERO G; MARSCHKE R; CAMORIANO JK; SORENSEN JM; SLOAN JA; RICHARDSON RL
      A DOSE-SEEKING TRIAL OF EDATREXATE IN COMBINATION WITH VINBLASTINE, ADRIAMYCIN, CISPLATIN, AND FILGRASTIM (EVAC G-CSF) IN PATIENTS WITH ADVANCED MALIGNANCIES - PROMISING ANTINEOPLASTIC ACTIVITY AGAINST NONSMALL CELL LUNG CARCINOMAS/

      The cancer journal from Scientific American
    76. DELEYN P; VANSTEENKISTE J; CUYPERS P; DENEFFE G; VANRAEMDONCK D; COOSEMANS W; VERSCHAKELEN J; LERUT T
      ROLE OF CERVICAL MEDIASTINOSCOPY IN STAGING OF NONSMALL CELL LUNG-CANCER WITHOUT ENLARGED MEDIASTINAL LYMPH-NODES ON CT SCAN

      European journal of cardio-thoracic surgery
    77. CORTESFUNES H; MARTIN C; ABRATT R; LUND B
      SAFETY PROFILE OF GEMCITABINE, A NOVEL ANTICANCER AGENT, IN NONSMALL CELL LUNG-CANCER

      Anti-cancer drugs
    78. BELLOTTI M; ELSNER B; DELIMA AP; ESTEVA H; MARCHEVSKY AM
      NEURAL NETWORKS AS A PROGNOSTIC TOOL FOR PATIENTS WITH NONSMALL CELL-CARCINOMA OF THE LUNG

      Modern pathology
    79. BERNARDI FD; ANTONANGELO L; BEYRUTI R; TAKAGAKI T; SALDIVA PHN; CAPELOZZI VL
      A PROGNOSTIC MODEL OF SURVIVAL IN SURGICALLY RESECTED SQUAMOUS-CELL CARCINOMA OF THE LUNG USING CLINICAL, PATHOLOGICAL, AND BIOLOGIC MARKERS

      Modern pathology
    80. MARTIN C; ARDIZZONI A; ROSSO R
      GEMCITABINE - SAFETY PROFILE AND EFFICACY IN NONSMALL CELL LUNG-CANCER UNAFFECTED BY AGE

      Aging
    81. TRAN TA; KALLAKURY BVS; SHEEHAN CE; ROSS JS
      EXPRESSION OF CD44 STANDARD FORM AND VARIANT ISOFORMS IN NONSMALL CELL LUNG CARCINOMAS

      Human pathology
    82. STRAYER DS; SCHWARTING R
      RECOGNITION OF NORMAL, NEOPLASTIC, AND FETAL AIRWAY EPITHELIAL-CELL MEMBRANES BY 2 MONOCLONAL-ANTIBODIES

      Human pathology
    83. MICHEL FB; PUJOL JL
      LUNG-CANCER - FROM EPIDEMIOLOGY TO MANAGEMENT

      La Semaine des hopitaux de Paris
    84. VANSTEENKISTE JF; STROOBANTS SG; DELEYN PR; DUPONT PJ; VERSCHAKELEN JA; NACKAERTS KL; MORTELMANS LA; DEMEDTS M; DENEFFE G; LERUT T; MENTEN J; VANUYTSEL L; VANDERSCHUEREN E; BUYSE B; DECAMER M; DELCROIX M; VANDENEECKHOUT A; VERLEDEN G; VANRAEMDONCK D; COOSEMANS W; HAUSTERMANS K; LAMBIN P; VANDENBOGAERT W; VANLIMBERGEN E; BAERT A; VERBEKEN E; DRIJKONINGEN R; LAUWERIJNS J
      MEDIASTINAL LYMPH-NODE STAGING WITH FDG-PET SCAN IN PATIENTS WITH POTENTIALLY OPERABLE NONSMALL CELL LUNG-CANCER - A PROSPECTIVE ANALYSIS OF 50 CASES

      Chest
    85. URSCHEL JD; FINLEY RK; TAKITA H
      LONG-TERM SURVIVAL AFTER BILATERAL ADRENALECTOMY FOR METASTATIC LUNG-CANCER - A CASE-REPORT

      Chest
    86. TAGA S; OSAKI T; OHGAMI A; IMOTO H; YOSHIMATSU T; YOSHINO I; YANO K; NAKANISHI R; ICHIYOSHI Y; YASUMOTO K
      PROGNOSTIC VALUE OF THE IMMUNOHISTOCHEMICAL DETECTION OF P16(INK4) EXPRESSION IN NONSMALL CELL LUNG-CARCINOMA

      Cancer
    87. MIYAJI K; FURUSE A; NAKAJIMA J; KOHNO T; OHTSUKA T; YAGYU K; OKA T; OMATA S
      THE STIFFNESS OF LYMPH-NODES CONTAINING LUNG-CARCINOMA METASTASES - ANEW DIAGNOSTIC PARAMETER MEASURED BY A TACTILE SENSOR

      Cancer
    88. CHO JY; KIM JH; LEE YH; CHUNG KY; KIM SK; GONG SJ; YOU NC; CHUNG HC; ROH JK; KIM BS
      CORRELATION BETWEEN K-RAS GENE MUTATION AND PROGNOSIS OF PATIENTS WITH NONSMALL CELL LUNG-CARCINOMA

      Cancer
    89. RENSHAW AA; MADGE R
      CERCARIFORM CELLS FOR HELPING DISTINGUISH TRANSITIONAL-CELL CARCINOMAFROM NONSMALL CELL LUNG-CARCINOMA IN FINE-NEEDLE ASPIRATES

      Acta cytologica
    90. WIELAND I; AMMERMULLER T; BOHM M; TOTZECK B; RAJEWSKY MF
      MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY AT THE HMLH1 LOCUS ON CHROMOSOME 3P21 OCCUR IN A SUBSET OF NONSMALL CELL LUNG CARCINOMAS

      Oncology research
    91. ICHIMURA E; MAESHIMA A; NAKAJIMA T; NAKAMURA T
      EXPRESSION OF C-MET HGF RECEPTOR IN HUMAN NONSMALL CELL LUNG CARCINOMAS IN-VITRO AND IN-VIVO AND ITS PROGNOSTIC-SIGNIFICANCE/

      Japanese journal of cancer research
    92. KUPELIAN PA; KOMAKI R; ALLEN P
      PROGNOSTIC FACTORS IN THE TREATMENT OF NODE-NEGATIVE NONSMALL CELL LUNG-CARCINOMA WITH RADIOTHERAPY ALONE

      International journal of radiation oncology, biology, physics
    93. ONEILL AJ; STAUNTON MJ; GAFFNEY EF
      APOPTOSIS OCCURS INDEPENDENTLY OF BCL-2 AND P53 OVER-EXPRESSION IN NONSMALL CELL LUNG-CARCINOMA

      Histopathology
    94. KWA HB; VERHEIJEN MGMM; LITVINOV SV; DIJKMAN JH; MOOI WJ; VANKRIEKEN JHJM
      PROGNOSTIC FACTORS IN RESECTED NONSMALL CELL LUNG-CANCER - AN IMMUNOHISTOCHEMICAL STUDY OF 39 CASES

      Lung cancer
    95. MATE JL; ARIZA A; ARACIL C; LOPEZ D; ISAMAT M; PEREZPITEIRA J; NAVASPALACIOS JJ
      CYCLIN D1 OVEREXPRESSION IN NONSMALL CELL LUNG-CARCINOMA - CORRELATION WITH KI67 LABELING INDEX AND POOR CYTOPLASMIC DIFFERENTIATION

      Journal of pathology
    96. PACCAGNELLA A; FAVARETTO A; ONIGA F; FESTI G; LAURO S; MORABITO A; OSSANA L; SARTORE F; DEPOLI F; FIORENTINO MV
      MITOMYCIN-C, VINBLASTINE, AND CARBOPLATIN REGIMEN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL

      Cancer
    97. ANGELETTI CA; LUCCHI M; FONTANINI G; MUSSI A; CHELLA A; RIBECHINI A; VIGNATI S; BEVILACQUA G
      PROGNOSTIC-SIGNIFICANCE OF TUMORAL ANGIOGENESIS IN COMPLETELY RESECTED LATE-STAGE LUNG-CARCINOMA (STAGE IIIA-N2) - IMPACT OF ADJUVANT THERAPIES IN A SUBSET OF PATIENTS AT HIGH-RISK OF RECURRENCE

      Cancer
    98. BAI F; NAKANISHI Y; KAWASAKI M; TAKAYAMA K; YATSUNAMI J; PEI XH; TSURUTA N; WAKAMATSU K; HARA N
      IMMUNOHISTOCHEMICAL EXPRESSION OF GLUTATHIONE-S-TRANSFERASE-PI CAN PREDICT CHEMOTHERAPY RESPONSE IN PATIENTS WITH NONSMALL CELL LUNG-CARCINOMA

      Cancer
    99. BRECHOT JM; CHEVRET S; CHARPENTIER MC; DEVECCHI CA; CAPRON F; PRUDENT J; ROCHEMAURE J; CHASTANG C
      BLOOD-VESSEL AND LYMPHATIC VESSEL INVASION IN RESECTED NONSMALL CELL LUNG-CARCINOMA - CORRELATION WITH TNM STAGE AND DISEASE-FREE AND OVERALL SURVIVAL

      Cancer
    100. PALOMARES MR; SAYRE JW; SHEKAR KC; LILLINGTON LM; CHLEBOWSKI RT
      GENDER INFLUENCE ON WEIGHT-LOSS PATTERN AND SURVIVAL OF NONSMALL CELLLUNG-CARCINOMA PATIENTS

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 23:04:01